The patent provides protection for Nanōmix's unique approach to mobile, point-of-care diagnostic testing.
The patent adds to Nanōmix's robust patent portfolio as they drive to commercialization of their POC test platform.
Larry K. Wray Ph.D. joins the Nanōmix team as Vice President of Development.
Receiving this certification demonstrates Nanōmix's committment to developing and delivering product of the highest standard.
The Nanōmix rapid POC tests utilize an innovative platform incorporating highly sensitive, low cost carbon nanostructure biosensors that can be used for a wide range of assays and sample types.
Read more ▶